PERSPECTA

News from every angle

Back to headlines

Sumitomo Pharma Co., Ltd. Reports Full-Year Earnings

Sumitomo Pharma Co., Ltd. announced GAAP EPS of \u00a5268.99 and revenue of \u00a5453.29 billion for its latest financial period.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.